As of the close on July 17, 2025, Blueprint Medicines Corporation's stock has gained approximately 11.00% over the past 52 weeks. The 50-day moving average sits at 118.23, while the 200-day moving average is 99.36.
| 52-Week Price Change | 11.00% |
| 50-Day Moving Average | 118.23 |
| 200-Day Moving Average | 99.36 |